Home › Funds › RTW INVESTMENTS, LP › ACAD
RTW INVESTMENTS, LP position in ACAD
ACADIA PHARMACEUTICALS INC · Health Care
RTW INVESTMENTS, LP reported holding 7,144,524 shares of ACAD (ACADIA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$144.0M, representing 1.45% of its reported portfolio and ranking #24 among its reported holdings. RTW INVESTMENTS, LP has disclosed ACAD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How RTW INVESTMENTS, LP's ACAD position evolved
RTW INVESTMENTS, LP first disclosed a stake in ACAD in Q3 2023 at 11,576,537 shares (US$241.3M). The position peaked in Q4 2023 at 11,253,551 shares, worth US$352.3M. Across 13 filings, RTW INVESTMENTS, LP increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 7,144,524 shares valued at US$144.0M. Notable position changes include a 36% trim in Q4 2024 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 11.58M | $241.26M | New |
| Q4 2023 | 11.25M | $352.35M | Reduce |
| Q1 2024 | 13.83M | $255.70M | Add |
| Q2 2024 | 13.71M | $222.75M | Reduce |
| Q3 2024 | 13.71M | $210.82M | Hold |
| Q4 2024 | 8.71M | $159.75M | Reduce |
| Q1 2025 | 8.54M | $141.85M | Reduce |
| Q2 2025 | 9.00M | $194.03M | Add |
| Q3 2025 | 7.14M | $152.46M | Reduce |
| Q4 2025 | 7.14M | $190.83M | Hold |
| Q1 2026 | 7.14M | $159.04M | Hold |
| Q2 2026 | 7.14M | $180.76M | Hold |
| Q3 2026 | 7.14M | $143.96M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ACAD and 13F data
ACAD (ACADIA PHARMACEUTICALS INC) is a Health Care company. 25 other funds we track also report a position in ACAD — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.09B), Palo Alto Investors LP (US$72.5M), BRAIDWELL LP (US$41.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ACAD
- BAKER BROS. ADVISORS LP 42.91M sh · $1.09B · Q2 2026
- Palo Alto Investors LP 2.86M sh · $72.46M · Q2 2026
- BRAIDWELL LP 1.65M sh · $41.65M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.44M sh · $36.39M · Q2 2026
More on RTW INVESTMENTS, LP
FAQ
How long has RTW INVESTMENTS, LP held ACAD?
RTW INVESTMENTS, LP has disclosed ACAD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is RTW INVESTMENTS, LP's current position in ACAD?
As of Q3 2026, RTW INVESTMENTS, LP holds 7.14M shares of ACAD (ACADIA PHARMACEUTICALS INC), valued at $143.96M, representing 1.45% of its reported portfolio and ranking #24.
Has RTW INVESTMENTS, LP been buying or selling ACAD?
In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP held unchanged its position in ACAD. The position peaked in Q4 2023 at 11.25M shares.
Which other funds hold ACAD?
Other major institutional holders of ACAD include BAKER BROS. ADVISORS LP, Palo Alto Investors LP, BRAIDWELL LP, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.